Regulation_NN of_IN the_DT BZLF1_NN promoter_NN of_IN Epstein-Barr_JJ virus_NN by_IN second_JJ messengers_NNS in_IN anti-immunoglobulin-treated_JJ B_NN cells_NNS ._.
We_PRP have_VBP now_RB investigated_VBN the_DT effect_NN of_IN oxLDLs_NNS on_IN blast_NN differentiation_NN ,_, on_IN IL-2_NN synthesis_NN and_CC on_IN the_DT activation_NN of_IN the_DT nuclear_JJ factor_NN kappaB_NN NF-kappaB_NN system_NN in_IN activated_VBN lymphocytes_NNS ._.
We_PRP have_VBP demonstrated_VBN earlier_RBR that_IN the_DT crosslinkage_NN of_IN the_DT complex_NN with_IN the_DT CD2_NN antigen_NN results_VBZ in_IN the_DT proliferation_NN of_IN normal_JJ human_JJ T_NN cells_NNS ._.
Whereas_IN peripheral_JJ T_NN cells_NNS can_MD undergo_VB forms_NNS of_IN positive_JJ selection_NN by_IN antigen-driven_JJ clonal_JJ expansion_NN and_CC negative_JJ selection_NN by_IN abortive_JJ stimulation_NN leading_VBG to_TO anergy_NN or_CC death_NN ,_, neither_DT is_VBZ exactly_RB the_DT same_JJ phenomenon_NN that_WDT occurs_VBZ in_IN the_DT thymic_JJ cortex_NN ._.
This_DT protein_NN also_RB binds_VBZ to_TO the_DT immunoglobulin_NN heavy-chain_NN enhancer_NN mu_NN E1_NN site_NN ._.
However_RB ,_, this_DT factor_NN did_VBD not_RB bind_VB to_TO a_DT typical_JJ AP-1_NN site_NN ._.
To_TO define_VB the_DT mechanism_NN underlying_VBG signal_NN transducer_NN and_CC activator_NN of_IN transcription_NN STAT_NN protein_NN recruitment_NN to_TO the_DT interleukin_NN 10_CD IL-10_NN receptor_NN ,_, the_DT STAT_NN proteins_NNS activated_VBN by_IN IL-10_NN in_IN different_JJ cell_NN populations_NNS were_VBD first_RB defined_VBN using_VBG electrophoretic_JJ mobility_NN shift_NN assays_NNS ._.
Conversely_RB ,_, diurnal_JJ rhythmicity_NN persisted_VBD in_IN apoplexy_NN patients_NNS lesions_NNS were_VBD in_IN the_DT cerebral_JJ cortex_NN ._.
In_IN addition_NN ,_, an_DT inhibitor_NN of_IN PKC_NN blocked_VBD both_CC activated_VBD ras_NN and_CC phorbol_NN ester_NN stimulation_NN ,_, suggesting_VBG a_DT role_NN for_IN ras_NN upstream_JJ of_IN PKC_NN ._.
Pentoxifylline_NN ,_, a_DT trisubstituted_JJ xanthine_NN derivative_NN ,_, has_VBZ been_VBN used_VBN to_TO decrease_VB blood_NN viscosity_NN and_CC is_VBZ reasonably_RB well_RB tolerated_VBN by_IN most_JJS recipients_NNS of_IN the_DT drug_NN ._.
